Literature DB >> 21812725

The utility of six over-the-counter (home) pregnancy tests.

Laurence A Cole1.   

Abstract

BACKGROUND: The home pregnancy market is rapidly evolving. It has moved from detection of pregnancy on the day of missed menstrual bleeding, to detection claims 4 days prior. It is moving from all manual tests to digital tests, with a monitor reading the bands and informing women they are pregnant. A thorough study is needed to investigate the validity of claims and evolving usefulness of devices.
METHODS: Studies were proposed to examine the sensitivity and specificity of home tests and their abilities to detect pregnancy. Methods examined the abilities of tests to detect human chorionic gonadotropin (hCG), hyperglycosylated hCG, free β-subunit, a mixture of these antigens in 40 individual early pregnancy urines.
RESULTS: Using a mixture of hCG, hyperglycosylated hCG and free β-subunit typical for early pregnancy, the sensitivity of the First Response manual and digital tests was 5.5 mIU/mL, while the sensitivities of the EPT and ClearBlue brand manual and digital tests was 22 mIU/mL. On further evaluation, the First Response manual and digital tests both detected 97% of 120 pregnancies on the day of missed menstrual bleeding. The EPT manual and digital devices detected 54% and 67% of pregnancies, respectively, and the ClearBlue manual and digital devices detected 64% and 54% of pregnancies, respectively.
CONCLUSIONS: First Response manual and digital claim >99% detection on the day of missed menses. The results here suggest similar sensitivity for these two tests. The EPT and ClearBlue manual and digital test make similar >99% claims, the data presented here disputes their elevated claim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812725     DOI: 10.1515/CCLM.2011.211

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  A low-cost smartphone-based platform for highly sensitive point-of-care testing with persistent luminescent phosphors.

Authors:  Andrew S Paterson; Balakrishnan Raja; Vinay Mandadi; Blane Townsend; Miles Lee; Alex Buell; Binh Vu; Jakoah Brgoch; Richard C Willson
Journal:  Lab Chip       Date:  2017-03-14       Impact factor: 6.799

2.  MEDIATION MODELS OF PREGNANCY DESIRES AND UNPLANNED PREGNANCY IN YOUNG, UNMARRIED WOMEN.

Authors:  Warren B Miller; Jennifer S Barber; Heather H Gatny
Journal:  J Biosoc Sci       Date:  2017-06-05

3.  Time-to-Pregnancy Associated With Couples' Use of Tobacco Products.

Authors:  Katherine J Sapra; Dana B Barr; José M Maisog; Rajeshwari Sundaram; Germaine M Buck Louis
Journal:  Nicotine Tob Res       Date:  2016-05-17       Impact factor: 4.244

4.  Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort.

Authors:  K J Sapra; G M Buck Louis; R Sundaram; K S Joseph; L M Bates; S Galea; C V Ananth
Journal:  Hum Reprod       Date:  2016-03-02       Impact factor: 6.918

5.  Time-Varying Effects of Signs and Symptoms on Pregnancy Loss <20 Weeks: Findings from a Preconception Prospective Cohort Study.

Authors:  Katherine J Sapra; Germaine M Buck Louis; Rajeshwari Sundaram; K S Joseph; Lisa M Bates; Sando Galea; Cande V Ananth
Journal:  Paediatr Perinat Epidemiol       Date:  2017-08-25       Impact factor: 3.980

6.  A multicolor multiplex lateral flow assay for high-sensitivity analyte detection using persistent luminescent nanophosphors.

Authors:  Adheesha N Danthanarayana; Erin Finley; Binh Vu; Katerina Kourentzi; Richard C Willson; Jakoah Brgoch
Journal:  Anal Methods       Date:  2019-12-10       Impact factor: 3.532

7.  Direct Reading of Bona Fide Barcode Assays for Diagnostics with Smartphone Apps.

Authors:  Jessica X H Wong; Xiaochun Li; Frank S F Liu; Hua-Zhong Yu
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

8.  Evidence-based pregnancy testing in clinical trials: Recommendations from a multi-stakeholder development process.

Authors:  Jessica E Morse; Sara B Calvert; Claire Jurkowski; Melissa Tassinari; Catherine A Sewell; Evan R Myers
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.